Atherosclerosis

Editorial board
pp. iii-iii(1)

Instructions to Authors
pp. I-II(2)

Ischemic preconditioning: nearly two decades of research. A comprehensive review
pp. 201-210(10)
Authors: Eisen A.; Fisman E.Z.; Rubenfire M.; Freimark D.; McKechnie R.; Tenenbaum A.; Motro M.; Adler Y.

Exclusive expression of transmembrane TNF- in mice reduces the inflammatory response in early lipid lesions of aortic sinus
pp. 211-218(8)
Authors: Canault M.; Peiretti F.; Mueller C.; Kopp F.; Morange P.; Rihs S.; Portugal H.; Juhan-Vague I.; Nalbone G.

Fluvastatin inhibits raft dependent Fc receptor signalling in human monocytes
pp. 219-228(10)
Authors: Hillyard D.Z.; Jardine A.G.; McDonald K.J.; Cameron A.J.M.

Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration
pp. 229-238(10)
Authors: Alvarez-Maqueda M.; El Bekay R.; Monteseirin J.; Alba G.; Chacon P.; Vega A.; Santa Maria C.; Tejedo J.R.; Martin-Nieto J.; Bedoya F.J.; Pintado E.; Sobrino F.

The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL
pp. 239-246(8)
Authors: Wang X.; Greilberger J.; Ledinski G.; Kager G.; Paigen B.; Jurgens G.

Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits
pp. 247-257(11)
Authors: Shimoji E.; Zhang B.; Fan P.; Saku K.

Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin
pp. 259-265(7)
Authors: Yamaguchi Y.; Matsuno S.; Kagota S.; Haginaka J.; Kunitomo M.

Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis
pp. 267-272(6)
Authors: Syvanne M.; Whittall R.A.; Turpeinen U.; Nieminen M.S.; Frick M.H.; Kesaniemi Y.A.; Pasternack A.; Humphries S.E.; Taskinen M.-R.

Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults
pp. 273-279(7)
Authors: Badiou S.; Merle De Boever C.; Dupuy A.-M.; Baillat V.; Cristol J.-P.; Reynes J.

Third generation oral contraceptive use and cardiovascular risk factors
pp. 281-286(6)
Authors: Doring A.; Frohlich M.; Lowel H.; Koenig W.

Lipoprotein concentrations in newborns are associated with allelic variations in their mothers
pp. 287-298(12)
Authors: Descamps O.S.; Bruniaux M.; Guilmot P.-F.; Tonglet R.; Heller F.R.

Biological determinants of serum ICAM-1, E-selectin, P-selectin and L-selectin levels in healthy subjects: the Stanislas study
pp. 299-308(10)
Authors: Ponthieux A.; Herbeth B.; Droesch S.; Haddy N.; Lambert D.; Visvikis S.

Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders
pp. 309-320(12)
Authors: Pisciotta L.; Hamilton-Craig I.; Tarugi P.; Bellocchio A.; Fasano T.; Alessandrini P.; Bon G.B.; Siepi D.; Mannarino E.; Cattin L.; Averna M.; Cefalu A.B.; Cantafora A.; Calandra S.; Bertolini S.

Is blood donation induced low iron status associated with favourable levels of OxLDL, s-ICAM-1, sVCAM-1 and vWF-antigen in healthy men
pp. 321-327(7)
Authors: Van Hoydonck P.G.A.; Schouten E.G.; Hoppenbrouwers K.P.M.; Temme E.H.M.

Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia
pp. 329-335(7)
Authors: Mohrschladt M.F.; Westendorp R.G.J.; Gevers Leuven J.A.; Smelt A.H.M.

Carotid atherosclerosis and cardiovascular risk factors: a comparison of residents of a rural area of Okinawa with residents of a typical suburban area of Fukuoka, Japan
pp. 337-343(7)
Authors: Tatsukawa M.; Sawayama Y.; Maeda N.; Okada K.; Furusyo N.; Kashiwagi S.; Hayashi J.

Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease
pp. 345-351(7)
Authors: Anderson R.; Dart A.M.; Starr J.; Shaw J.; Chin-Dusting J.P.F.

Prevalence and correlates of carotid atherosclerosis among elderly Japanese men
pp. 353-359(7)
Authors: Kitamura A.; Iso H.; Imano H.; Ohira T.; Sato S.; Naito Y.; Iida M.; Shimamoto T.

Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort
pp. 361-365(5)
Authors: Levy A.P.; Larson M.G.; Corey D.; Lotan R.; Vita J.A.; Benjamin E.J.

Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation
pp. 367-373(7)
Authors: Tremblay A.J.; Lamarche B.; Ruel I.; Hogue J.-C.; Bergeron J.; Gagne C.; Couture P.

Effect of fibrates on postprandial remnant-like particles in patients with combined hyperlipidemia
pp. 375-382(8)
Authors: Ooi T.C.; Cousins M.; Ooi D.S.; Nakajima K.; Edwards A.L.

Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid Metabolic Syndrome
pp. 383-389(7)
Authors: Dell'Omo G.; Penno G.; Pucci L.; Mariani M.; Del Prato S.; Pedrinelli R.

Influenza-a trigger for acute myocardial infarction
pp. 391-391(1)
Authors: Dvorakova A.; Poledne R.

Author Index
pp. 393-396(4)

Subject Index
pp. 397-398(2)